OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Showing 8 citing articles:
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study
Chiara Bellitto, Nicoletta Luxi, Francesco Ciccimarra, et al.
Drug Safety (2024) Vol. 47, Iss. 10, pp. 1011-1023
Open Access | Times Cited: 3
Chiara Bellitto, Nicoletta Luxi, Francesco Ciccimarra, et al.
Drug Safety (2024) Vol. 47, Iss. 10, pp. 1011-1023
Open Access | Times Cited: 3
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients
Zesheng An, Gabriel Figueroa‐Parra, Xian Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Zesheng An, Gabriel Figueroa‐Parra, Xian Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126165-126165
Open Access | Times Cited: 1
Shanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126165-126165
Open Access | Times Cited: 1
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
Andrea Picchianti Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 4
Andrea Picchianti Diamanti, Assunta Navarra, Alessandra Aiello, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 4
Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends
Xiufang Kong, Wei Wang
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 2, pp. 81-89
Open Access
Xiufang Kong, Wei Wang
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 2, pp. 81-89
Open Access
Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting
María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 672-672
Open Access
María Torres-Rufas, Esther F. Vicente‐Rabaneda, Laura Cardeñoso, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 672-672
Open Access
The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands
C. Ouaddouh, Janneke W. Duijster, Thomas Lieber, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 3, pp. 323-331
Open Access
C. Ouaddouh, Janneke W. Duijster, Thomas Lieber, et al.
Expert Opinion on Drug Safety (2023) Vol. 23, Iss. 3, pp. 323-331
Open Access
Editorial to the Special Issue “Clinical Immunology in Italy, with Special Emphasis to Primary and Acquired Immunodeficiencies: A Commemorative Issue in Honor of Prof. Fernando Aiuti”
Alessandro Aiuti, Raffaele D’Amelio, Isabella Quinti, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3191-3191
Open Access
Alessandro Aiuti, Raffaele D’Amelio, Isabella Quinti, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3191-3191
Open Access
